Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ICU Medical, Inc. - Common Stock (NQ: ICUI )

174.57 +2.27 (+1.32%)
Streaming Delayed Price Updated: 12:34 PM EST, Jan 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading. 
Via Benzinga
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in... 
Via Benzinga
Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Smiths Acquisition Weighs On ICU Medical's Profitability, Shares Fall
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
Expert Ratings for ICU Medical
  Analysts have provided the following ratings for ICU Medical (NASDAQ:ICUI) within the last quarter: 
Via Benzinga
ICU Medical: Q2 Earnings Insights
  ICU Medical (NASDAQ:ICUI) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
ICU Medical's Return On Capital Employed Insights
ICU Medical (NASDAQ:ICUI) brought in sales totaling $543.12 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 291.06%, resulting in a loss of $38.07 million. 
Via Benzinga
Morgan Stanley And 2 Other Stocks Insiders Are Buying
Although US stocks closed sharply higher on Friday, there were a few notable insider trades. 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut PubMatic, Inc. (NASDAQ: PUBM) price target from $48 to $27. PubMatic shares fell 1.5% to $18.71 in pre-market trading. 
Via Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
Health care stocks have some advantages in the current market environment. 
Via Investor's Business Daily
Recap: ICU Medical Q4 Earnings
ICU Medical (NASDAQ:ICUI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ICU... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name... 
Via Benzinga
ICU Medical, inc (ICUI) Q3 2021 Earnings Call Transcript
ICUI earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
Exposures Pension
ICU Medical Pulls Amino Acid IV Products After Foreign Substances Found In Batch
ICU Medical Inc (NASDAQ: ICUI), a California-based infusion therapy company, is voluntarily recalling one lot of an amino acid injection after reports of fibers,... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading.... 
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
A Peek Into The Markets: US Stock Futures Fall Ahead Of Jobless Claims, Fed Speakers
Pre-open movers U.S. stock futures traded lower in early pre-market trade after recording losses in the previous session. Investors are awaiting earnings results from Hovnanian... 
Via Benzinga
Topics Economy
Exposures Interest Rates
54 Biggest Movers From Yesterday
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to... 
Via Benzinga
Why ICU Medical Stock Is Jumping Today
A leading manufacturer of intravenous therapy solutions is about to get a lot bigger. 
Via The Motley Fool
Why ICU Medical Shares Surged Today
ICU Medical (NASDAQ: ICUI) shares are trading higher after the company announced it will acquire Smiths Medical division from Smiths Group PLC for $2.35 billion in cash and stock... 
Via Benzinga
Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also fell, dropping 0.20% to 4,510.78. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
ICUI Stock: What Is the Huge News Sending ICU Medical Soaring 35% Today
Today, a big acquisition deal has sent shares of ICU Medical more than 30% higher as investors and speculators buy into ICUI stock. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.